Evidence map›Paper›PMID 40763878›Full record

ArticleArchivos de cardiologia de Mexico2025

Immunization and cardiovascular disease in Latin America. The CorVacc study: rationale and design.

Fernando Wyss, Ricardo Lopez-Santi, Daniel Piskorz, Shyla Gupta, Ana Munera-Echeverri, Pilar Lopez-Santi, Gonzalo Piskorz, Vladimir Ulluauri, Juan E Gomez, Mildren Del Sueldo and 18 more

Abstract read
In one paragraph

Article in Archivos de cardiologia de Mexico, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Fernando WyssServicios y Tecnología Cardiovascular de Guatemala-CARDIOSOLUTIONS, Guatemala.
Ricardo Lopez-SantiHospital Italiano de la Plata, La Plata, Argentina.
Daniel PiskorzUnidad de Cardiología Sanatorio Británico, Rosario, Argentina.
Shyla GuptaUniversity of Ottawa, Faculty of Medicine, Ottawa, Canadá.
Ana Munera-EcheverriHospital General de Medellín, Medellín, Colombia.
Pilar Lopez-SantiLeiden University Medical Center, Leids Universitair Medish Centrum, Leiden, Holanda.
Gonzalo PiskorzData IQ, Buenos Aires, Argentina.
Vladimir UlluauriHospital Metropolitano de Quito, Quito, Ecuador.
Juan E GomezFundacion Valle de Lili, Unidad de Cardiología, Cali, Colombia.
Mildren Del SueldoClínica de Especialidades Villa María, Córdoba, Argentina.
Claudia AlmonteCEMDOE Unidad de Cardiología, Santo Domingo, República Dominicana.
Máxima MendezCli-Lipid, Santo Domingo, República Dominicana.
Osiris ValdezHospital Central de la Romana, La Romana, Republica Dominicana.
Carlos I Ponte-NegretiInstituto Medico la Floresta, Caracas, Venezuela.
Iván Romero-RiveraUniversidade Federal de Alagoas, Alagoas, Brasil.
Adriana Puente-BarraganCentro Medico Nacional XX de Noviembre, Ciudad de México, México.
Raúl VillarBUPA Integra Medica la Serena, La Serena, Chile.
Julio EffioPanama Clínic-Hospital Santa Fe, Panamá, Panamá.
Daniel PichelUniversidad de Panamá-Hospital Paitilla, Panamá, Panamá.
Percy BerrospiSANNA Clínica el Golf, Lima, Perú.
Ana I BarrientosHospital Bendaña, San Pedro Sula, Honduras.
Nancy SilveraSanatorio Santani, Asunción, Paraguay.
Edmundo JordanHospital Pavía Santurce Cardiology Center, San Juan, Puerto Rico.
Wistremundo DonesHospital Ryder Memorial, Humacao, Puerto Rico.
Daniel QuezadaHospital San Vicente de Paul, San José, Costa Rica.
Ariel ArguelloHospital Vivian Pellas, Managua, Nicaragua.
Gonzalo PerezClinica Olivos, Buenos Aires, Argentina.
Adrián BaranchukKingston Health Sciences Centre, Queens University, Kingston, Canadá.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the rates of vaccination against influenza and pneumococcal disease in the general population of the Americas, both healthy and sick, and to analyze the factors influencing these rates.

methodsThe Inter-American Vaccination Registry of Influenza and Pneumococcus, (CorVacc Study) is a cross-sectional survey of the general population that will be enacted in 19 Latin American countries. A total of 34 questions will be given to consecutive patients aged 18 years or older through an online survey.

resultsThe data will be analyzed by country and region according to seven clusters: demographics, socioeconomic and educational level, cardiometabolic profile, cardiovascular interventions, medical follow-up and treatments, and COVID-19 vaccination status. The study will be conducted by the Prevention Council of the Inter-American Society of Cardiology.

conclusionsThis study will provide insight into the impact of influenza and pneumococcus vaccinations in Latin American populations and the barriers preventing the immunization targets from being actualized. Hopefully, this will help to facilitate the development of targeted and focused health prevention strategies.

Indexed as

Cardiovascular DiseasesInfluenza, HumanInfluenza VaccinesPneumococcal InfectionsPneumococcal VaccinesVaccinationAdultCOVID-19Cross-Sectional StudiesHumansLatin AmericaMaleRegistriesResearch DesignInfluenza VaccinesPneumococcal VaccinesInfluenzaNeumococoPneumococcusVaccinesVacunas

Identifiers

PMID40763878
PMCPMC12324838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.